Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $3.07 per share versus the Zacks Consensus Estimate of a loss of $2.15. This compares to loss of $10.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -42.79%. A quarter ago, it was expected that this company would post a loss of $4 per share when it actually produced earnings of $0.75, delivering a surprise of 118.75%.Over the last four quarters, the company ...